VERITAS Vision System for Phacoemulsification Receives FDA Clearance and CE Mark

Johnson & Johnson Vision has announced the FDA 510(k) clearance and CE mark of a new high-performance phacoemulsification system designed to improve the procedures of cataract surgeons. The next-generation VERITAS™ Vision System incorporates advancements that will allow surgeons to guide through any lens density with less surge and more stability. The new system also provides enhancements in ergonomics to further enhance usability during cataract surgery. 

Phacoemulsification is the most common technique performed for cataract surgeries, which is one of the most prevalent outpatient procedures performed today. The technique allows ophthalmologists to effectively emulsify and efficiently remove the eye’s internal lens when it has become cloudy from cataracts. It is a delicate procedure that requires significant effort and control during surgery, which can be taxing on the surgeon. 

“While the phacoemulsification technique has been used successfully for decades, ease of use continues to be the unmet need with cataract surgeons,” said Rajesh K. Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision. “Every aspect of Johnson & Johnson Vision’s new VERITAS™ System was designed to give surgeons an excellent user experience – optimizing features for safety and efficiency, with improvements in two main areas: fluidics and ergonomics.”

The VERITAS™ Vision System FDA clearance and CE mark further underscore Johnson & Johnson Vison’s commitment to innovation and meeting the unmet needs of eye care professionals and patients. Last month, the company also announced the FDA approval of the TECNIS® EYHANCE and TECNIS® EYHANCE TORIC II intraocular lens (IOL) for the treatment of cataract patients in the United States. Both innovations come as the company celebrates the anniversary of its TECNIS® platform, the proprietary combination of materials and design on which the company’s IOLs are built. The TECNIS® platform is responsible for two decades of breakthroughs in cataract treatment. 

A full commercial launch of the VERITAS™ Vision System globally is expected later this year.